Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREMED: Prevention of Macular Edema after Cataract Surgery
NL-OMON41658Phase 3Active, not recruiting
- Sponsor
- Maastricht University Medical Center+
- Start
- Jul 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Monoclonal Antibodies → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of bromfenac sodium, dexamethasone sodium phosphate, triamcinolone acetonide and bevacizumab in Irvine-Gass syndrome (IGS) (7 arms), sponsored by Maastricht University Medical Center+. Started Jul 2013; status: active, not recruiting.
02
Drugs
bromfenac sodiumdexamethasone sodium phosphatetriamcinolone acetonidebevacizumab
03
Conditions
Irvine-Gass syndrome (IGS)
Beyond the preview
Go deeper on NL-OMON41658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41658.